Comments on: An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral Etavopivat, a Pyruvate Kinase Activator in Patients With Sickle Cell Disease (HIBISCUS)

Comments on: An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral Etavopivat, a Pyruvate Kinase Activator in Patients With Sickle Cell Disease (HIBISCUS) https://scdstudies.com/an-adaptive-randomized-placebo-controlled-double-blind-multi-center-study-of-oral-etavopivat-a-pyruvate-kinase-activator-in-patients-with-sickle-cell-disease-hibiscus/?utm_source=rss&utm_medium=rss&utm_campaign=an-adaptive-randomized-placebo-controlled-double-blind-multi-center-study-of-oral-etavopivat-a-pyruvate-kinase-activator-in-patients-with-sickle-cell-disease-hibiscus Sat, 22 Jun 2024 12:24:58 +0000 hourly 1 https://wordpress.org/?v=6.7.1